B537 - Support surveillance of Severe Acute Respiratory Illness

This Notice is issued in accordance with Federal Acquisition Regulation (FAR) subpart 5.201 to notify the public of a proposed contract action.

The proposed contract action is to provide up-to-date epidemiological and laboratory data on respiratory pathogens that are circulating within Cairo, Egypt, and the morbidity and mortality associated with each pathogen, for use by the Faculty of Medicine Ain Shams, NAMRU- EURAFCENT and the Egyptian Center for Research and Regenerative Medicine.

The NAVSUP FLC Sigonella intends to solicit and negotiate with only one source under the authority of FAR 6.302-1 by entering into a sole source contract with Ain Shams University Hospitals.

The Ain Shams University Hospitals is the only known source able to provide the required services.

See the DRAFT Sole Source Justification and Draft Performance Work Statement for additional information.

The statutory authority permitting other than full and open competition is 41 U.S.C.253(c)(1) as implemented by the Federal Acquisition Regulation (FAR) Subpart 6.302-1 entitled 3304(a)(1) sole source specifications, which reads in part, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

This notice of intent in not a request for capability statements or competitive proposals; however any firm who believes it can perform the required services may give written notice to the Contracting Officer within 05 days of publication of this Special Notice.

Supporting evidence must be in sufficient detail to demonstrate the ability to comply with the requirement.

Responses received will be evaluated; however a determination by the Government to compete the requirement based on the responses to this Special Notice is solely the discretion of the Government